• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Pfizer

NIH launches study of allergic reactions to COVID-19 vaccines

April 7, 2021 By Chris Newmarker Leave a Comment

The NIH today announced that a clinical trial is underway to study whether people who are highly allergic or have a mast cell disorder are more likely to develop an allergic reaction to the Moderna or Pfizer-BioNTech COVID-19 vaccines. Reports of severe allergic reactions to COVID-19 vaccines have made headlines since the rollout to the […]

Filed Under: Clinical Trials, Featured, Pharmaceutical Tagged With: BioNTech, coronavirus, COVID-19, COVID-19 vaccine trial, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Pfizer

Pfizer-BioNTech COVID-19 vaccine 91.3% effective after six months

April 1, 2021 By Brian Buntz Leave a Comment

The first COVID-19 vaccine to win emergency use authorization in the U.S. is highly effective for at least six months after the second dose. Developed jointly by Pfizer (NYSE: PFE) and BioNTech (NSDQ: BNTX), the BNT162b2 vaccine The durability of COVID-19 vaccines had been something of an open question, although early clinical data suggested that Moderna’s mRNA-1273 […]

Filed Under: Blog, Pharmaceutical Tagged With: BioNTech, coronavirus, COVID-19, mRNA-1273, Pfizer

Pfizer, BioNTech report COVID-19 vaccine works well among adolescents

March 31, 2021 By Sean Whooley Leave a Comment

Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX) announced today that their COVID-19 vaccine produced 100% efficacy among adolescents. In adolescents aged 12 to 15 years old with or without prior evidence of SARS-CoV-2 infection, the BNT162b2 vaccine demonstrated 100% efficacy and robust antibody responses, exceeding those recorded earlier in vaccinated participants between 16 and 25. The vaccine […]

Filed Under: Clinical Trials, Featured, Pharmaceutical Tagged With: BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Pfizer

EU allows Pfizer/BioNTech COVID-19 vaccine to be stored at higher temperatures

March 26, 2021 By Sean Whooley

Pfizer and BioNTech announced today that European authorities approved storage of their COVID-19 vaccine at a new temperature. Based on data showing stability in standard pharmaceutical freezers, the European Medicines Agency (EMA) approved storage of the vaccine at -25°C to -15°C for a total of two weeks. The FDA’s requirements include two-week storage at the same temperatures, […]

Filed Under: Featured, Pharmaceutical Tagged With: BioNTech, coronavirus, COVID-19, COVID-19 vaccine, European Medicines Agency (EMA), European Union, Pfizer

Early Pfizer COVID-19 vaccine doses may have had potency problems

March 25, 2021 By Brian Buntz

Some of the first commercially available doses of Pfizer-BioNTech COVID-19 vaccine had lower levels of intact mRNA than anticipated, according to leaked documents reviewed by BMJ. The documents in question relate to a December breach of the European Medicines Agency (EMA), which was one of the many victims of pharma-related cyber breaches in 2020. A Pfizer […]

Filed Under: Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, EMA, Pfizer

Pfizer launches trial for novel oral COVID-19 therapeutic

March 23, 2021 By Brian Buntz

An experimental oral antiviral from Pfizer will be the focus of a Phase 1 study involving healthy adults. Known as PF-07321332, the drug has shown promise during in vitro studies against SARS-CoV-2. PF-07321332 belongs to a class of drugs known as protease inhibitors, which are commonly used to treat HIV/AIDS and hepatitis C. Protease inhibitors bind to […]

Filed Under: Featured, Pharmaceutical Tagged With: Clinical Trials, coronavirus, COVID-19, Pfizer

MedTech 100 roundup: Small dip keeps industry down

March 22, 2021 By Sean Whooley

The last month brought a bit of a skid for the medtech industry and after a slight rebound last week, the downward trend has returned. A strong start to 2021 came to an end in late February and carried over into March, with MassDevice‘s MedTech 100 index hitting its lowest point on March 8 (102.16). It […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Bigfoot Biomedical, coronavirus, COVID-19, Joe Biden, MedTech 100 Index, Medtronic, Pfizer, Roche, Viz.ai

Pfizer exec reportedly says COVID-19 vaccine pricing is a ‘signficant opportunity’ post-pandemic

March 18, 2021 By Sean Whooley

Pfizer CFO & EVP of supply chain Frank D’Amelio has said there could be an opportunity to potentially hike up prices on its COVID-19 vaccine in a post-pandemic state. Speaking last week at the Barclays Global Healthcare Conference, D’Amelio revealed that the company is considering what will become of the vaccine situation, especially involving pricing, […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Pharmaceutical Tagged With: BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Pfizer

Novax could have one of the most-effective COVID-19 vaccines

March 12, 2021 By Brian Buntz

Novavax (Gaithersburg, Md.) may not be the best-known vaccine developer, but its COVID-19 vaccine offers performance in line with those from Moderna and Pfizer. Its vaccine was 96.4% effective at preventing COVID-19 caused by the original strain of the virus in a Phase 3 study. The Moderna and Pfizer vaccines offered efficacy in the mid-90% […]

Filed Under: Pharmaceutical Tagged With: BioNTech, Clinical Trials, coronavirus, COVID-19, Moderna, Novavax, Novavax Inc., Pfizer

Pfizer-BioNTech vaccine dramatically reduces death risk from COVID-19, study finds

March 12, 2021 By Brian Buntz

Recent real-world data from the Israel Ministry of Health found that unvaccinated individuals were 29 times more likely to die due to COVID-19 complications than those who received two doses of the BNT162b2 Pfizer-BioNTech vaccine.  Also, those who were unvaccinated were 44 times more likely to contract symptomatic COVID-19.  The data also suggest that the […]

Filed Under: Featured, Pharmaceutical Tagged With: BioNTech, Clinical Trials, coronavirus, COVID-19, COVID-19 vaccine, Pfizer

Why emergency authorization of COVID-19 therapies could pose regulatory questions

March 11, 2021 By Brian Buntz

Few of the COVID-19 therapies in use in the U.S. have won full FDA approval. The widespread use of emergency use authorization may accelerate the distribution of disease-modifying agents and vaccines to patients, but it also could cause regulatory complications. “I’m nervous about the prospect of there never being a COVID vaccine that meets the […]

Filed Under: Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: COVID-19, FDA, Johnson & Johnson, Moderna, Pfizer, Regulatory, VRBPAC

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 13
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS